Despite further analyses in a subgroup of patients with no copies of the ApoE4 gene, known to have a lower risk of ARIA, the ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

If  you're looking for a low-risk growth stock that also happens to be outperforming the S&P 500 (^GSPC-0.33%) so far this ...

Novo Nordisk’s (NVO) stock has dropped by 25% in March (on the Copenhagen exchange) to put it on track for its biggest ...

We recently published a list of 10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher In this article, we are ...

Novo Nordisk's (NYSE: NVO) is famous and celebrated for its cutting-edge obesity medication. Its U.S.-traded American ...

Eli Lilly LLY -2.21% Get Free Report has outperformed the market over the past 20 years by 6.51% on an annualized basis ...

Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Eli Lilly & Co (LLY – Research Report). The company’s shares ...

Tommy Bahama owner Oxford Industries warned consumers are pulling back on their spending and new tariffs will impact results.

Oxford Industries, Inc. faces weak sales, declining margins, and poor guidance for FY25. Click for why OXM trades at a premium despite underperformance.

VIG's recent rebalancing impacts its holdings, yield, and dividend growth streak. Read here for a comparison with SPY, DGRO, ...